Insider Transactions for Turning Point Therapeutics, Inc. (TPTX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanChief Scientific OfficerDec 06, 2019Sale$50.7750,8902,583,5881,086,482Dec 09, 2019, 08:44 PM
TPTXTurning Point Therapeutics, Inc.GLAXOSMITHKLINE PLCDirectorSep 10, 2019Buy$45.00177,7777,999,9652,170,327Sep 12, 2019, 04:18 PM
TPTXTurning Point Therapeutics, Inc.George SimeonDirectorSep 10, 2019Buy$45.00177,7777,999,9652,170,327Sep 11, 2019, 06:42 PM
TPTXTurning Point Therapeutics, Inc.Larson YiEVP & Chief Financial OfficerSep 10, 2019Buy$45.002,22299,9902,222Sep 11, 2019, 04:16 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOSep 10, 2019Buy$45.0010,000450,00022,000Sep 11, 2019, 04:15 PM
TPTXTurning Point Therapeutics, Inc.Chen BihuaDirectorMay 14, 2019Option Exercise$2.1923,26851,0623,122,367May 16, 2019, 04:15 PM
TPTXTurning Point Therapeutics, Inc.Chen BihuaDirectorApr 22, 2019Buy$18.00400,0007,200,0003,099,099Apr 25, 2019, 04:08 PM
TPTXTurning Point Therapeutics, Inc.GLAXOSMITHKLINE PLCDirectorApr 22, 2019Buy$18.00325,0005,850,0001,992,550Apr 24, 2019, 07:28 PM
TPTXTurning Point Therapeutics, Inc.ORBIMED ADVISORS LLCDirectorApr 22, 2019Buy$18.00360,0006,480,0002,027,550Apr 24, 2019, 06:16 PM
TPTXTurning Point Therapeutics, Inc.Lu HongboDirectorApr 22, 2019Buy$18.0060,0001,080,0001,727,550Apr 24, 2019, 06:11 PM
TPTXTurning Point Therapeutics, Inc.GORDON CARL LDirectorApr 22, 2019Buy$18.00360,0006,480,0002,027,550Apr 24, 2019, 06:07 PM
TPTXTurning Point Therapeutics, Inc.George SimeonDirectorApr 22, 2019Buy$18.00325,0005,850,0001,992,550Apr 24, 2019, 06:04 PM
TPTXTurning Point Therapeutics, Inc.Baker Brian LeeVP of Finance and Admin.Apr 22, 2019Buy$18.002,80050,4002,800Apr 24, 2019, 06:00 PM
TPTXTurning Point Therapeutics, Inc.Countouriotis AthenaPresident & CEOApr 22, 2019Buy$18.0012,000216,00012,000Apr 24, 2019, 05:55 PM